Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
1.770
-0.030 (-1.67%)
Mar 2, 2026, 4:00 PM EST - Market closed
Serina Therapeutics Stock Forecast
SER's stock price has decreased by -64.46% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Serina Therapeutics stock have an average target of 13, with a low estimate of 11 and a high estimate of 15. The average target predicts an increase of 634.46% from the current stock price of 1.77.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 28, 2025.
Analyst Ratings
The average analyst rating for Serina Therapeutics stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +747.46% | Aug 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +747.46% | Jul 14, 2025 |
| Jones Trading | Jones Trading | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +521.47% | Mar 11, 2025 |
Financial Forecast
Revenue This Year
131.30K
from 56.00K
Increased by 134.46%
Revenue Next Year
n/a
from 131.30K
EPS This Year
-2.03
from -1.51
EPS Next Year
-1.82
from -2.03
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 136,500 | n/a | ||||
| Avg | 131,300 | n/a | ||||
| Low | 127,400 | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 143.8% | - | ||||
| Avg | 134.5% | - | ||||
| Low | 127.5% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -2.11 | -1.88 | ||||
| Avg | -2.03 | -1.82 | ||||
| Low | -1.97 | -1.78 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.